Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAP2K1 | Q02750 | 12/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.50 |
| ▸ | RET | P07949 | 4/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.42 |
| ▸ | POLB | P06746 | 1/20 | 0.42 |
| ▸ | HTT | P42858 | 1/20 | 0.42 |
| ▸ | RECQL | P46063 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6054312 | 0.87 | MAP2K1 (0.55) | MAP2K1ALDH1A1RETKDM4EPOLB | |
| SCHEMBL6054378 | 0.85 | MAP2K1 (0.53) | MAP2K1RETKDM4EPOLBHTT | |
| SCHEMBL6054328 | 0.83 | RET (0.54) | MAP2K1RET | |
| SCHEMBL6054224 | 0.82 | MAP2K1 (0.58) | MAP2K1ALDH1A1RETKDM4EPOLB | |
| SCHEMBL6054246 | 0.82 | MAP2K1 (0.59) | MAP2K1ALDH1A1RETKDM4E | |
| SCHEMBL6054292 | 0.79 | MAP2K1 (0.61) | MAP2K1ALDH1A1KDM4EPOLBHTT | |
| SCHEMBL3687662 | 0.79 | MAP2K1 (0.63) | MAP2K1ALDH1A1KDM4EPOLBHTT | |
| SCHEMBL3692161 | 0.73 | MAP2K1 (0.96) | MAP2K1ALDH1A1KDM4EHTT | |
| SCHEMBL3690032 | 0.73 | MAP2K1 (0.62) | MAP2K1KDM4EPOLBHTTRECQL | |
| SCHEMBL6054273 | 0.72 | MAP2K1 (0.61) | MAP2K1KDM4EPOLBHTTRECQL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7030112-B2 | Pyrrolopyridazine compounds and methods of use thereof for the treatment of proliferative disorders | BRISTOL-MYERS SQUIBB COMPANY (US) | 2006-04-18 | — | — | US | claimed |
| US-7030112-B2 | Pyrrolopyridazine compounds and methods of use thereof for the treatment of proliferative disorders | BRISTOL-MYERS SQUIBB COMPANY (US) | 2006-04-18 | — | — | US | disclosed |